Revenue increased 27% year over year to $72.6 million  Adjusted EBITDA of $4.4 million for the year   PLAINVIEW, N.Y. March 30, 2016 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months and year ended December 31, 2016. “We are pleased to announce a record revenue of $72.6 million...
Read More

Management to Hold Investor Conference Call on March 30, 2017 at 10:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / March 23, 2017 / Vaso Corporation (OTC PINK: VASO) announced today that it will release its financial results for the year ended December 31, 2016 on Thursday, March 30, 2017, before market open. The Company will...
Read More

Quarterly Revenue Increased to $17.5 Million PLAINVIEW, NY / ACCESSWIRE / November 14, 2016 / Vaso Corporation (OTC PK: VASO) (formerly Vasomedical, Inc.) today reported its operating results for the three months ended September 30, 2016. “We are pleased to report that the Company achieved continued revenue growth to $17.5 million for the third quarter...
Read More

Management to Hold Investor Conference Call on November 14, 2016 at 1:00 p.m. ET PLAINVIEW, NY / ACCESSWIRE / November 7, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months ended September 30, 2016 on Monday, November 14, 2016, before market open. The Company will...
Read More

Mr. Simon Srybnik is named Chairman Emeritus PLAINVIEW, NY / ACCESSWIRE / August 22, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today announced the appointment of Mr. Joshua Markowitz as Chairman of the Board of Directors of the Company, effective August 19, 2016. An investor in various areas including healthcare, Mr. Markowitz has served...
Read More